| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer
1 company
Tanguler Tolga is an EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 86 sells.
Estimated insider holdings value: $8.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 1,510 | $362.87 | $547,927.38 | -0.2% | -13.2% | - | |
| Oct 2, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 1,405 | $452.05 | $635,126.28 | -0.4% | -13.7% | - | |
| Aug 29, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 3,474 | $448.37 | $1,557,649.44 | -2.1% | +1.1% | - | |
| Aug 18, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 1,396 | $453.27 | $632,758.71 | -0.6% | +0.8% | - | |
| Mar 3, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 471 | $243.78 | $114,820.42 | -0.3% | +25.7% | +30.9% | |
| Feb 28, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sale+OE | 513 | $241.68 | $123,983.10 | -0.4% | +18.7% | +34.9% | |
| Nov 26, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 1,469 | $250.98 | $368,685.86 | -2.1% | -1.7% | +75.7% | |
| Jun 25, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 1,605 | $231.00 | $370,747.09 | -1.1% | +13.2% | +34.1% | |
| Feb 28, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sale+OE | 501 | $155.30 | $77,805.43 | -1.8% | -3.3% | +52.7% | |
| Feb 16, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, Chief Commercial Officer | Sell | 1,009 | $148.06 | $149,396.69 | -7.2% | +2.9% | +74.5% |